We must (begrudgingly) move on from the Covid trials and remember that Revive’s (patented) Bucillamine is medically effective for so much more than (only) Covid. We challenge CEO Michael Frank to now bring home the bacon despite him and us long term investors facing loss fortunes on paper as it stands. Disappointment aside, “Bonjour” from the South of France!
Market Data 
Markets 
